Xanax (Alprazolam) is Contraindicated in PTSD
Benzodiazepines, including Xanax (alprazolam), should be avoided in patients with PTSD as they may worsen outcomes and are considered relatively contraindicated for this condition. 1
Evidence Against Benzodiazepine Use in PTSD
Clinical Guidelines and Research
- The American College of Physicians and the American Academy of Sleep Medicine explicitly recommend against benzodiazepines in PTSD treatment, citing moderate-certainty evidence supporting their ineffectiveness 1
- Benzodiazepines have been found ineffective for both PTSD treatment and prevention, with risks that outweigh potential short-term benefits 2
- A systematic review and meta-analysis of 18 clinical trials with 5,236 participants concluded that benzodiazepines should be considered relatively contraindicated for patients with PTSD or recent trauma 2
Specific Concerns with Alprazolam in PTSD
Severe withdrawal symptoms have been documented when discontinuing alprazolam in PTSD patients, including:
- Increased anxiety and hyperalertness
- Sleep disturbance
- Rage reactions
- Increased nightmares and intrusive thoughts
- Homicidal ideation (reported in 6 of 8 patients in one study) 3
Early administration of benzodiazepines (including alprazolam) to trauma survivors did not show beneficial effects on illness course and was associated with higher rates of PTSD development (9 of 13 benzodiazepine-treated patients vs. 3 of 13 controls met PTSD criteria at 6 months) 4
Recommended Alternatives for PTSD Treatment
First-Line Treatments
- Trauma-focused psychotherapy is recommended as the primary treatment for PTSD 1
- FDA-approved medications:
For PTSD-Related Sleep Disturbances and Nightmares
- Prazosin is specifically recommended for PTSD-related nightmares (starting dose 1 mg at bedtime) 1
- Trazodone (25-600 mg, mean 212 mg) may be considered for sleep disturbance 1
- Image rehearsal therapy, a modified cognitive behavioral therapy technique, is recommended for PTSD-associated nightmares 1
Risks of Benzodiazepine Use in PTSD
Benzodiazepines in PTSD patients are associated with:
- Worse overall PTSD severity
- Significantly increased risk of developing PTSD when used after recent trauma
- Poorer psychotherapy outcomes
- Increased aggression, depression, and substance use 2
- Risk of dependence and severe withdrawal symptoms, even with gradual tapering 3
Special Considerations
- The prevalence of long-term concurrent use of benzodiazepines with opioids in PTSD patients has increased significantly (52.7% in men and 79.5% in women over a 9-year period), raising additional safety concerns 5
- Despite guidelines recommending against benzodiazepines, studies show they continue to be prescribed to approximately 14% of veterans with PTSD in the absence of clearly indicated co-occurring psychiatric diagnoses 6
When treating anxiety, insomnia, or other symptoms in PTSD patients, clinicians should prioritize evidence-based treatments rather than benzodiazepines, given their potential to worsen long-term outcomes and create additional complications in this vulnerable population.